Company Registration No. 09276399 (England and Wales)
Wyvern Pharma Ltd
Filleted accounts
for the year ended 30 September 2023
Wyvern Pharma Ltd
Filleted accounts
Contents
Wyvern Pharma Ltd
Company Information
for the year ended 30 September 2023
Director
Ahmed Altaf Zackaria
Company Number
09276399 (England and Wales)
Registered Office
Wyvern Pharmacy
81 Abbey Street
Accrington
BB5 1EH
England
Accountants
YP Finance
Hawthorne House
17A Hawthorne Drive
Leicester
Leicestershire
LE5 6DL
Wyvern Pharma Ltd
Statement of financial position
as at 30 September 2023
Tangible assets
38,437
1,219
Cash at bank and in hand
45,404
-
Creditors: amounts falling due within one year
(158,726)
(59,919)
Net current liabilities
(59,850)
(1,962)
Total assets less current liabilities
(21,413)
(743)
Provisions for liabilities
Other provisions
(232)
(232)
Net liabilities
(21,645)
(975)
Called up share capital
2
4
Profit and loss account
(21,647)
(979)
Shareholders' funds
(21,645)
(975)
For the year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 September 2024 and were signed on its behalf by
Ahmed Altaf Zackaria
Director
Company Registration No. 09276399
Wyvern Pharma Ltd
Notes to the Accounts
for the year ended 30 September 2023
Wyvern Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 09276399. The registered office is Wyvern Pharmacy, 81 Abbey Street, Accrington, BB5 1EH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
15% reducing balance
Motor vehicles
20% straight line
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
Wyvern Pharma Ltd
Notes to the Accounts
for the year ended 30 September 2023
4
Tangible fixed assets
Plant & machinery
Motor vehicles
Total
Cost or valuation
At cost
At cost
At 1 October 2022
1,487
-
1,487
At 30 September 2023
1,487
46,751
48,238
At 1 October 2022
268
-
268
Charge for the year
183
9,350
9,533
At 30 September 2023
451
9,350
9,801
At 30 September 2023
1,036
37,401
38,437
At 30 September 2022
1,219
-
1,219
Finished goods
9,500
9,805
Amounts falling due within one year
Trade debtors
39,580
37,910
Accrued income and prepayments
-
686
7
Creditors: amounts falling due within one year
2023
2022
Bank loans and overdrafts
-
1,545
Trade creditors
44,372
57,627
Taxes and social security
7,807
560
Other creditors
104,728
99
Loans from directors
312
-
Wyvern Pharma Ltd
Notes to the Accounts
for the year ended 30 September 2023
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2
2
- A Ordinary Shares of £1 each
-
1
- B Ordinary Shares of £1 each
-
1
9
Average number of employees
During the year the average number of employees was 6 (2022: 7).